Optison
Optison is a pharmaceutical drug with 11 clinical trials. Historical success rate of 75.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
2
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
54.5%
6 of 11 finished
45.5%
5 ended early
0
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Two and Three Dimensional Contrast-enhanced Ultrasound for Screening of Renal Cell Carcinoma Recurrence Following Cryoablation
Detection of Coronary Stenosis With Intravenous Microbubbles
Contrast-Enhanced Ultrasound and Shear Wave Elastography for the Treatment of Lymphedema
Study to Determine Safety and Dosage of OPTISON in Pediatric Participants
Myocardial Perfusion Echocardiography to Detect Human Heart Transplant Rejection
Clinical Trials (11)
Two and Three Dimensional Contrast-enhanced Ultrasound for Screening of Renal Cell Carcinoma Recurrence Following Cryoablation
Detection of Coronary Stenosis With Intravenous Microbubbles
Contrast-Enhanced Ultrasound and Shear Wave Elastography for the Treatment of Lymphedema
Study to Determine Safety and Dosage of OPTISON in Pediatric Participants
Myocardial Perfusion Echocardiography to Detect Human Heart Transplant Rejection
IRB 14-009240, Does CEUS Positively Influence Selection of Biopsy Sites When Evaluating Transplant Kidneys?
CeVUS With Intravesical Administration of OPTISON TM (Trademark) in Children
Contrast-Enhanced Ultrasound in Human Crohn's Disease
Assessing Myocardial Blood Flow and Blood Flow Reserve by Transoesophageal Echocardiography (TEE)
Dose-Finding, Feasibility Study of Optison in Contrast Enhanced U/S for the Detection of Carotid Artery Disease
Determination of a Safe Dose of Optison in Pediatric Patients With Solid Tumors
All 11 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 11